5-Amino-1MQ oral capsules offer a convenient, non-injectable form of this NNMT inhibitor for metabolic research, typically dosed at 50mg per capsule. By blocking nicotinamide N-methyltransferase, the oral version boosts NAD+ levels, enhances mitochondrial function, and supports fat metabolism, insulin sensitivity, and energy production in preclinical studies. With superior bioavailability compared to injectable peptides, it’s ideal for lab investigations into weight management, anti-aging, and cellular repair without needles.

Product Specifications